Research updates from MicroCD Labs.

Field note · July 24, 2026

Organ-on-chip and 3D culture systems expand human-relevant testing.

Conventional two-dimensional cell cultures cannot reproduce every feature of living tissue. Three-dimensional culture and organ-on-chip systems provide controlled environments in which cells can organize, interact, and respond to flow or mechanical cues in ways that may better reflect aspects of human physiology.

Microfluidic organ-chip devices can support disease modeling, drug-response studies, and toxicity research using living human cells. These approaches may reduce reliance on some animal studies, but broader validation, standardization, and fit-for-purpose evidence are still needed before they can replace established models across drug development.

Selected references: Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors; Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?; and the Wyss Institute Human Organs-on-Chips program.

Field note · July 24, 2026

Microfluidics is moving selected tests closer to patients.

By integrating sample preparation, fluid handling, reagents, and detection into compact devices, microfluidic systems can reduce the sample volume and equipment required for some diagnostic workflows. This is especially relevant where centralized laboratory infrastructure or trained operators are difficult to access.

University of Washington research led by Paul Yager has explored low-cost, instrument-minimized point-of-care tests using paper and porous-media fluidics. Wearable researchers, including teams associated with the University of Cincinnati, have also investigated microfluidic sweat collection as a less invasive route for measuring selected biomarkers.

These technologies remain application-specific. A sweat measurement is not automatically equivalent to a blood measurement, and smartphone imaging or control does not by itself establish analytical or clinical validity. Sampling, calibration, interference, stability, and intended-use validation remain central development questions.

Selected references: Enabling a Microfluidic Immunoassay for the Developing World by Integration of On-Card Dry Reagent Storage; Bioanalytical Devices: Technological Leap for Sweat Sensing; and A Wearable Patch for Continuous Analysis of Thermoregulatory Sweat at Rest.